GEORGE YANCOPOULOS - Bd. Co-Chair, President & CSO, Director at REGENERON PHARMACEUTICALS, INC.

Insider Transactions and Holdings

Entity Type
Individual
Role
Bd. Co-Chair, President & CSO, Director
Stock Symbol
REGN on Nasdaq
All Insider Reports
All Insider Reports

There are no Buy or Sell transactions made by GEORGE YANCOPOULOS since 27 Dec 2024

Holdings reported by GEORGE YANCOPOULOS for REGENERON PHARMACEUTICALS, INC.

Security Num Shares Value Price $ Transaction Date Ownership Underlying Class Underlying Amount
Common Stock 869K $882M $1,015.02 10 Jun 2024 Direct
Common Stock 180K $183M $1,015.02 10 Jun 2024 By Trust for Chldn.
Common Stock 56K $56.9M $1,015.02 10 Jun 2024 by Children
Common Stock 5.9K $5.99M $1,015.02 10 Jun 2024 By 401(k) Plan
Common Stock 0 $0 $1,015.02 10 Jun 2024 by 2022 GRAT II
2019 Performance Stock Units 0 $844.09 11 Dec 2023 Direct Common Stock
Non-Qualified Stock Option (right to buy) 0 15 Feb 2024 Direct Common Stock

Transactions reported by GEORGE YANCOPOULOS for REGENERON PHARMACEUTICALS, INC.

Sym Class Transaction % Value $ * Price $ Shares Shares After Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.